Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRML | VZLA |
|---|---|---|
| Price | $7.06 | $3.42 |
| Change today | ▼ 4.08% | ▼ 3.12% |
| Market cap | $1.04B | $1.21B |
| Return, 3 months | -16.6% | +8.2% |
| Return, year to date | +1.7% | -37.5% |
| Return, 1 year | -40.1% | -27.8% |
| P/E (TTM) | -3.8 | -19.0 |
| P/B | 3.0 | 2.9 |
| P/E percentile vs own 5y | 39th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -340.0% | -1,721.8% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | -104.7% | -14.0% |
| Analyst target vs. price | +117.1% | – |
| Analyst buy share | 67% | – |
| RSI (14) | 47 | 35 |
| 30-day volatility | 121.0% | 54.6% |
| Max drawdown, 1 year | -82.9% | -56.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
